Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.
about
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaAnalysis for loss of heterozygosity (LOH) of p53 allele in tumors derived from p53+/- and CD-1 mice following repeated subcutaneous injections of solutions containing antioxidants.Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies.Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis.Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers.Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in sizeFrequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinomaGenetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus.The polymerase chain reaction in histopathology.Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue.Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesionsp53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens.Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.Intraperitoneal dedifferentiated liposarcoma: a case report.In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma.Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung.Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridizationSelective genetic analysis of p53 immunostain positive cells.Relationship between biomarker expression and allelic alteration in esophageal carcinoma.p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
P2860
Q21563424-FD240705-5D42-40EA-896B-86319841B185Q31913520-F59A5615-B541-484F-9B08-FADFC023B3FFQ32090180-28942702-2A2A-46B7-9DE5-0E0038B52433Q33869648-7B9865C9-82F0-4F05-AA90-792F1C51346EQ34319309-6240C767-8A3C-44E5-A5F8-7B1391DB7870Q35367235-568D9934-9961-457C-B189-D739823E65B3Q35763819-31A2E9B7-0CFA-4867-966E-3231F65B86B9Q35794862-7AFF9B10-16E2-4B9E-BBB7-BF52827644C5Q36079960-C7BF7838-0012-4DA8-BB81-2ADBFF5EBF7AQ36080877-7F07911D-F336-4D86-8900-F54DA11D4594Q36109030-3CA602A3-20B2-4B99-83D1-94ECA52E5697Q36228101-2E9189CF-DAD8-4FBC-A4D0-C142A09D240FQ36287125-9F611AD5-6574-4080-AD7A-00B50F32A5A9Q36570795-9FC104B4-44FA-4ECB-AFF6-FC8850120218Q36619645-A0A8852E-ACD1-4164-B11E-D85454DACFD3Q36709579-808DE90F-DF2F-4D3A-AD89-EEFFD6547092Q36869517-62407CAF-9D41-495B-B09D-AAA9A243E966Q36951846-9E4152C9-7699-4B3F-9F21-AF09081FA6A3Q37262914-343497D7-1B78-46EF-93EB-B8CB545C914FQ37640813-B304A9D6-29F5-49E6-BFFA-72CEC1C98EF3Q38487094-544F8365-6129-44D7-A43B-060513B7480EQ41017427-8DCFC84D-F5B5-4B09-9961-88539379E761Q41851796-926F033D-7017-43B1-8BB1-58750AFE5CEDQ42050334-20A44DEF-DAEB-4084-8791-0CE1CC7B8A04Q42063011-956BB3E8-8D6B-431F-BA33-48C484326B5DQ42437998-DC932FBA-ADEF-4941-A0EE-93C8327FA3C8Q42754365-BE99267E-D849-4B95-BF2F-339ED92D4650Q42937114-082C3AE5-E9EF-48D0-92CE-6E5F85D71F5BQ46887416-C6FB0063-3BDE-4915-85AD-871328032E3CQ50974656-64CE9865-1B3A-4ECC-B6B9-BFB13E80113BQ55030365-7B284689-11A5-4150-9A78-0BFDB61B4292
P2860
Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduction to homozygosity invo ...... the polymerase chain reaction.
@en
Reduction to homozygosity invo ...... the polymerase chain reaction.
@nl
type
label
Reduction to homozygosity invo ...... the polymerase chain reaction.
@en
Reduction to homozygosity invo ...... the polymerase chain reaction.
@nl
prefLabel
Reduction to homozygosity invo ...... the polymerase chain reaction.
@en
Reduction to homozygosity invo ...... the polymerase chain reaction.
@nl
P2093
P2860
P356
P1476
Reduction to homozygosity invo ...... the polymerase chain reaction.
@en
P2093
S J Meltzer
T K McDaniel
P2860
P304
P356
10.1073/PNAS.88.11.4976
P407
P577
1991-06-01T00:00:00Z